Filing Flows › Health Care › Microbot Medical (MBOT)

Microbot Medical (MBOT) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 11, 2026 · Microbot Medical (MBOT) Q2 2026 earnings results →

Microbot Medical made $241K in Q2 2026. Operating margin n/m, net loss $5.6M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 11, 2026.

Revenue$241K

Year over year—

Operating marginn/m

Net earnings−$5.6M

Operating cash flow−$5.0M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $241K in Q2 2026, up 130% from the previous quarter.

Operating costs exceeded revenue by $6.2M, an operating margin of -2567.6%. The quarter ended with a net loss of $5.6M, wider than the previous quarter's $3.7M loss.

Operating cash flow was −$5.0M. Non-cash charges added back $15K of depreciation and amortization and $433K of share-based compensation. Capital expenditures of $142K exceeded it, leaving free cash flow of −$5.1M.

Quarterly history

Quarter	Form	Filed	Revenue	Y/Y	Op. margin	Net earnings	Op. cash flow
Q2 2026	10-Q	Aug 11, 2026	$241K	—	n/m	−$5.6M	−$5.0M
Q1 2026	10-Q	May 13, 2026	$105K	—	n/m	−$3.7M	−$5.1M

Charts

From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.

Latest (Q2 2026): Net income −$5.6M, Operating cash flow −$5.0M.

+114.4% since FY2020: more shares outstanding (issuance, stock pay); earlier years scaled for the 3-for-1 split before FY2025.